Peripheral Arterial Disease Trial, Recruiting (NCT04347200)

Peripheral Arterial Disease Trial, Recruiting NCT04347200 Sponsor: National Medical Research Center for Cardiology, Ministry of Health of Russian Federation Condition: Peripheral Arterial Disease

Printed from Voxsanity (voxsanity.com.au) — NCT04347200 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Peripheral Arterial Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with coronary artery disease (narrowed or blocked heart arteries), confirmed by a past heart attack, a procedure to open blocked arteries, or clear evidence seen on a heart scan or imaging test.

Who may not be able to join:

You are not willing or able to give your written agreement to take part in the study.
You had a serious heart event (such as a heart attack or unstable chest pain) within the last 12 months.
You have very severe heart failure that severely limits your daily activity (confirm with trial site).
You had a stroke within the last 6 months.
You have a severe liver disease or severe muscle disease.
You have severe kidney disease, where a specific blood test result (creatinine) is above a certain level.
The trial team would not be able to contact you or a family member for a follow-up check one year after taking part.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 21 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Elizaveta Panchenko, PhD, National Medical Research Center for Cardiology, Ministry of Health of Russian Federation

Phone: +79161813257

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04347200

Sponsor: National Medical Research Center for Cardiology, Ministry of Health of Russian Federation

Phase: Not Applicable

Status: Recruiting

Condition: Peripheral Arterial Disease

Trial contact: +79161813257

More information: https://clinicaltrials.gov/study/NCT04347200

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with coronary artery disease (narrowed or blocked heart arteries), confirmed by a past heart attack, a procedure to open blocked arteries, or clear evidence seen on a heart scan or imaging test.

Who may not be able to join:

You are not willing or able to give your written agreement to take part in the study.
You had a serious heart event (such as a heart attack or unstable chest pain) within the last 12 months.
You have very severe heart failure that severely limits your daily activity (confirm with trial site).
You had a stroke within the last 6 months.
You have a severe liver disease or severe muscle disease.
You have severe kidney disease, where a specific blood test result (creatinine) is above a certain level.
The trial team would not be able to contact you or a family member for a follow-up check one year after taking part.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 21 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

National Medical Research Center for Cardiology, Ministry of Health of Russian Federation

Registry

ClinicalTrials.gov

Start date

15 January 2015

Est. completion

31 December 2026

Where this trial is recruiting

🇷🇺 Russia

Primary endpoints

composite of major adverse cardiovascular events (MACE); composite of any bleeding events

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov